Aspen Aerogels Inc
NYSE:ASPN

Watchlist Manager
Aspen Aerogels Inc Logo
Aspen Aerogels Inc
NYSE:ASPN
Watchlist
Price: 5.79 USD -2.2% Market Closed
Market Cap: 475.4m USD
Section:
Wall Street Price Targets
Wall Street Price Targets
Revenue Forecast
Operating Income Forecast
Net Income Forecast
See Also
Price Target
Loading...
Revenue
Loading...
Operating Income
Loading...
Net Income
Loading...

Wall Street
Price Targets

ASPN Price Targets Summary
Aspen Aerogels Inc

Wall Street analysts forecast ASPN stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for ASPN is 12.68 USD with a low forecast of 7.07 USD and a high forecast of 33.6 USD.

ASPN Lowest Forecast
Wall Street Target
7.07 USD
22% Upside
ASPN Average Forecast
Wall Street Target
12.68 USD
119% Upside
ASPN Highest Forecast
Wall Street Target
33.6 USD
480% Upside
Lowest
Price Target
7.07 USD
22% Upside
Average
Price Target
12.68 USD
119% Upside
Highest
Price Target
33.6 USD
480% Upside
Aspen Aerogels Inc Competitors:
Price Targets
S
SYENS
Syensqo SA
26% Upside
4046
Osaka Soda Co Ltd
12% Upside
603601
Chongqing Zaisheng Technology Co Ltd
18% Upside
ASIANPAINT
Asian Paints Ltd
2% Upside
S
SYENS
Syensqo SA
26% Upside
4046
Osaka Soda Co Ltd
12% Upside
603601
Chongqing Zaisheng Technology Co Ltd
18% Upside
ASIANPAINT
Asian Paints Ltd
2% Upside
600352
Zhejiang Longsheng Group Co Ltd
25% Upside
S
300037
Shenzhen Capchem Technology Co Ltd
27% Upside
A
121600
Advanced Nano Products Co Ltd
233% Upside
UZU
Uzin Utz AG
30% Upside

Revenue
Forecast

Revenue Estimate
Aspen Aerogels Inc

For the last 8 years the compound annual growth rate for Aspen Aerogels Inc's revenue is 18%. The projected CAGR for the next 3 years is 4%.

18%
Past Growth
4%
Estimated Growth
Estimates Accuracy
-1%
Average Miss
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
Aspen Aerogels Inc

The compound annual growth rate of Aspen Aerogels Inc's operating income for the next 3 years is 13%.

N/A
Past Growth
13%
Estimated Growth
Estimates Accuracy
6%
Average Beat
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
Aspen Aerogels Inc

The compound annual growth rate of Aspen Aerogels Inc's net income for the next 3 years is 68%.

N/A
Past Growth
68%
Estimated Growth
Estimates Accuracy
-56%
Average Miss
What are analyst estimates?

See Also

Summary
ASPN intrinsic value, competitors valuation, and company profile.
DCF Valuation
ASPN stock valuation using Discount Cash Flow valuation method.
Relative Valuation
ASPN stock valuation using valuation multiples.
Wall Street Estimates
ASPN price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
ASPN stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is ASPN's stock price target?
Price Target
12.68 USD

According to Wall Street analysts, the average 1-year price target for ASPN is 12.68 USD with a low forecast of 7.07 USD and a high forecast of 33.6 USD.

What is Aspen Aerogels Inc's Revenue forecast?
Projected CAGR
4%

For the last 8 years the compound annual growth rate for Aspen Aerogels Inc's revenue is 18%. The projected CAGR for the next 3 years is 4%.

What is Aspen Aerogels Inc's Operating Income forecast?
Projected CAGR
13%

The compound annual growth rate of Aspen Aerogels Inc's operating income for the next 3 years is 13%.

What is Aspen Aerogels Inc's Net Income forecast?
Projected CAGR
68%

The compound annual growth rate of Aspen Aerogels Inc's net income for the next 3 years is 68%.

Back to Top
ALPHA SPREAD
Follow us
Join more than 263,100+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.